XML 90 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Narrative) (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Investments, Owned, Federal Income Tax Note [Line Items]        
Effective income tax rate 42.00% 28.00%    
Net deferred tax liability $ 20,764,000 $ 23,185,000    
Valuation allowances against deferred tax assets 32,860,000 17,942,000 $ 13,282,000 $ 7,170,000
Federal net operating loss carryforwards related to the acquisitions of Cardiogenesis and Hemosphere 1,300,000      
State net operating loss carryforwards 1,500,000      
Foreign net operating loss carryforwards 443,000      
Research and development tax credit carryforwards 293,000      
Other tax credit 81,000      
Excess interest carryforward 6,438,000 5,559,000    
Interest deduction limit 20,400,000 8,100,000    
Non-current liabilities recorded related to interest and penalties on uncertain tax positions 372,000 358,000    
Penalties and interest income (expense) 6,500 145,000 (35,000)  
Total uncertain tax liability including interest and penalties 5,200,000 4,900,000    
Uncertain tax liability recorded as reduction to deferred tax assets 100,000 100,000    
Uncertain tax liability recorded to non-current liability 5,100,000 4,800,000    
Approximate amount that would affect tax rate 4,400,000 $ 3,600,000 $ 3,200,000  
Approximate amount of uncertain tax liability to be recognized 100,000      
Foreign Authority        
Investments, Owned, Federal Income Tax Note [Line Items]        
Net deferred tax liability $ 119,000